{"id":"https://openalex.org/W4213072175","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.487","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial.","display_name":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial.","publication_year":2022,"publication_date":"2022-02-16","ids":{"openalex":"https://openalex.org/W4213072175","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.487"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.6_suppl.487","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.487","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.487","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089861374","display_name":"Thomas B. Powles","orcid":"https://orcid.org/0000-0001-7760-4724","observed_orcids":["https://orcid.org/0000-0001-7760-4724"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Powles","raw_affiliation_strings":["Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St Bartholomew\u2019s Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St Bartholomew\u2019s Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057146015","display_name":"Se Hoon Park","orcid":"https://orcid.org/0000-0001-5084-9326","observed_orcids":["https://orcid.org/0000-0001-5084-9326"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Se Hoon Park","raw_affiliation_strings":["Sungkyunkwan University Samsung Medical Center, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sungkyunkwan University Samsung Medical Center, Seoul, South Korea;","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006671522","display_name":"\u00c9ric Voog","orcid":"https://orcid.org/0000-0001-8366-8003","observed_orcids":["https://orcid.org/0000-0001-8366-8003"]},"institutions":[{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eric Voog","raw_affiliation_strings":["Centre Jean Bernard Clinique Victor Hugo, Le Mans, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Bernard Clinique Victor Hugo, Le Mans, France;","institution_ids":["https://openalex.org/I4210123491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064767706","display_name":"Claudia Caserta","orcid":"https://orcid.org/0009-0003-3721-4520","observed_orcids":["https://orcid.org/0009-0003-3721-4520"]},"institutions":[{"id":"https://openalex.org/I4210123105","display_name":"Azienda Ospedaliera S.Maria","ror":"https://ror.org/02t96cy48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123105"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Caserta","raw_affiliation_strings":["Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy;","institution_ids":["https://openalex.org/I4210123105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017439917","display_name":"Bego\u00f1a P\u00e9rez\u2010Valderrama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bego\u00f1a P\u00e9rez-Valderrama","raw_affiliation_strings":["Hospital Universitario Virgen del Roc\u00edo, Seville, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Roc\u00edo, Seville, Spain;","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041526616","display_name":"Howard Gurney","orcid":"https://orcid.org/0000-0003-0217-5261","observed_orcids":["https://orcid.org/0000-0003-0217-5261"]},"institutions":[{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Howard Gurney","raw_affiliation_strings":["Macquarie University, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Macquarie University, Sydney, Australia;","institution_ids":["https://openalex.org/I99043593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027991868","display_name":"Yohann Loriot","orcid":"https://orcid.org/0000-0002-8338-1739","observed_orcids":["https://orcid.org/0000-0002-8338-1739"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yohann Loriot","raw_affiliation_strings":["Gustave Roussy, INSERMU981, Universit\u00e9 Paris-Saclay, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, INSERMU981, Universit\u00e9 Paris-Saclay, Villejuif, France;","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044972820","display_name":"Srikala S. Sridhar","orcid":"https://orcid.org/0000-0002-6994-1285","observed_orcids":["https://orcid.org/0000-0002-6994-1285"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Srikala S. Sridhar","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027892519","display_name":"Norihiko Tsuchiya","orcid":"https://orcid.org/0000-0003-4242-2618","observed_orcids":["https://orcid.org/0000-0003-4242-2618"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norihiko Tsuchiya","raw_affiliation_strings":["Yamagata University Faculty of Medicine, Yamagata, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yamagata University Faculty of Medicine, Yamagata, Japan;","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004985848","display_name":"Cora Nanette Sternberg","orcid":"https://orcid.org/0000-0003-3938-2627","observed_orcids":["https://orcid.org/0000-0003-3938-2627"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cora N. Sternberg","raw_affiliation_strings":["Englander Institute for Precision Medicine, Weill Cornell Medicine, Hematology/Oncology, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Englander Institute for Precision Medicine, Weill Cornell Medicine, Hematology/Oncology, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074756323","display_name":"Joaquim Bellmunt B","orcid":"https://orcid.org/0000-0003-2328-3421","observed_orcids":["https://orcid.org/0000-0003-2328-3421","https://orcid.org/0000-0001-7569-7074"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joaquim Bellmunt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036848171","display_name":"Jeanny B. Aragon\u2010Ching","orcid":"https://orcid.org/0000-0002-6714-141X","observed_orcids":["https://orcid.org/0000-0002-6714-141X"]},"institutions":[{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanny B. Aragon-Ching","raw_affiliation_strings":["Inova Schar Cancer Institute, Fairfax, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inova Schar Cancer Institute, Fairfax, VA;","institution_ids":["https://openalex.org/I2800468613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050042851","display_name":"Daniel Peter Petrylak","orcid":"https://orcid.org/0000-0001-6165-5797","observed_orcids":["https://orcid.org/0000-0001-6165-5797"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel P. Petrylak","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT;","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008012629","display_name":"Andy Blake-Haskins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andy Blake-Haskins","raw_affiliation_strings":["Pfizer, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, La Jolla, CA;","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112751347","display_name":"Robert J Laliberte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J Laliberte","raw_affiliation_strings":["Pfizer, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Cambridge, MA;","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jing Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["Pfizer, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Cambridge, MA;","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015679960","display_name":"Nuno Matos Costa","orcid":"https://orcid.org/0009-0003-0676-2065","observed_orcids":["https://orcid.org/0009-0003-0676-2065"]},"institutions":[{"id":"https://openalex.org/I4405254080","display_name":"Pfizer (Portugal)","ror":"https://ror.org/01ctjz153","country_code":"PT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4405254080"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Nuno Matos Costa","raw_affiliation_strings":["Pfizer, Porto Salvo, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Porto Salvo, Portugal;","institution_ids":["https://openalex.org/I4405254080"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026717218","display_name":"Petros D. Grivas","orcid":"https://orcid.org/0000-0003-3965-3394","observed_orcids":["https://orcid.org/0000-0003-3965-3394"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Petros Grivas","raw_affiliation_strings":["University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA;","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":24,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6_suppl","first_page":"487","last_page":"487"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7279999852180481},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8560000061988831},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8339999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7020000219345093},{"id":"https://openalex.org/keywords/best-supportive-care","display_name":"best supportive care","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.5600000023841858},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4560000002384186},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.40700000524520874},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.37400001287460327},{"id":"https://openalex.org/keywords/locally-advanced-disease","display_name":"locally advanced disease","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9201393127441406},{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.8937712907791138},{"id":"https://openalex.org/C2911057145","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Metastatic Urothelial Carcinoma","level":5,"score":0.705078125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5850330591201782},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.5826009511947632},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5678279995918274},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.452981561422348},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.45088234543800354},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.450065016746521},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4464694857597351},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4458782374858856},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.42003750801086426},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.37322863936424255},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3666052520275116},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.3543453812599182},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.32291287183761597},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2700154781341553},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.26023632287979126},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.17326432466506958},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16215035319328308}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.6_suppl.487","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.487","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.487","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366339435","https://openalex.org/W4286298696","https://openalex.org/W4286295522","https://openalex.org/W4295836740","https://openalex.org/W3135777660","https://openalex.org/W4360606821","https://openalex.org/W3087874197","https://openalex.org/W4324136701","https://openalex.org/W4310753917","https://openalex.org/W7130741148"],"abstract_inverted_index":{"487":[0],"Background:":[1],"The":[2,102],"phase":[3],"3":[4],"JAVELIN":[5,267],"Bladder":[6,268],"100":[7,269],"trial":[8,54,270,309],"(NCT02603432)":[9],"showed":[10],"significantly":[11,162],"longer":[12,163,196],"overall":[13],"survival":[14,126],"(OS)":[15],"with":[16,29,36,56,71,81,116,180,197,211,252,257,276,297,304],"avelumab":[17,96,166,198,217,254,277,291],"+":[18,87,97,167,199,218,278],"best":[19],"supportive":[20],"care":[21,48],"(BSC)":[22],"vs":[23,169,201,227,244,280],"BSC":[24,98,100,168,170,200,202,219,221,279,281],"alone":[25,171,203,222],"in":[26,49,59,110,114,149,164,173,178,204,209,241,295],"patients":[27],"(pts)":[28],"advanced":[30,74,298],"UC":[31,77,299],"that":[32,300],"had":[33,140],"not":[34,302],"progressed":[35,303],"1L":[37,41,85,293,305],"platinum-containing":[38,306],"chemotherapy.":[39,307],"Avelumab":[40],"maintenance":[42,294],"is":[43],"now":[44],"considered":[45],"standard":[46],"of":[47,84],"treatment":[50],"guidelines.":[51],"We":[52],"report":[53],"data":[55,155],"\u22652-years":[57],"follow-up":[58,145,264],"all":[60,111,153,174,205],"pts":[61,112,115,132,176,179,207,210,230,296],"(additional":[62],"19":[63],"months":[64,148],"from":[65,108,265],"the":[66,165,216,266,287],"initial":[67],"analysis).":[68],"Methods:":[69],"Pts":[70],"unresectable":[72],"locally":[73],"or":[75,89,99],"metastatic":[76],"without":[78],"disease":[79],"progression":[80],"4-6":[82],"cycles":[83],"gemcitabine":[86],"cisplatin":[88],"carboplatin":[90],"were":[91,133],"randomized":[92,134,175,206],"1:1":[93],"to":[94,272],"receive":[95],"alone.":[101,282],"primary":[103],"endpoint":[104],"was":[105,187,195,250],"OS,":[106],"assessed":[107],"randomization":[109],"and":[113,128,177,208,220],"PD-L1+":[117,141,181,212],"tumors":[118,182,213],"(Ventana":[119],"SP263":[120],"assay).":[121],"Secondary":[122],"endpoints":[123],"included":[124],"progression-free":[125],"(PFS)":[127],"safety.":[129],"Results:":[130],"700":[131],"(350":[135],"per":[136],"arm);":[137],"358":[138],"(51.1%)":[139],"tumors.":[142],"With":[143],"extended":[144],"(median,":[146],"\u226538":[147],"both":[150],"arms":[151],"for":[152,290],"pts;":[154],"cutoff,":[156],"June":[157],"4,":[158],"2021),":[159],"OS":[160,185,275],"remained":[161],"arm":[172],"(Table).":[183,214],"An":[184],"benefit":[186],"observed":[188],"across":[189],"prespecified":[190],"subgroups.":[191],"PFS":[192],"(by":[193],"investigator)":[194],"In":[215],"arms,":[223],"respectively,":[224],"185":[225],"(52.9%)":[226],"252":[228],"(72.0%)":[229],"received":[231],"a":[232,238],"subsequent":[233],"anticancer":[234],"drug":[235],"therapy,":[236],"including":[237],"PD-(L)1":[239],"inhibitor":[240],"40":[242],"(11.4%)":[243],"186":[245],"(53.1%)":[246],"pts.":[247],"Long-term":[248,263],"safety":[249,260],"consistent":[251],"previous":[253],"monotherapy":[255],"studies,":[256],"no":[258],"new":[259],"signals.":[261],"Conclusions:":[262],"continues":[271],"show":[273],"prolonged":[274],"These":[283],"results":[284],"further":[285],"support":[286],"standard-of-care":[288],"role":[289],"as":[292],"has":[301],"Clinical":[308],"information:":[310],"NCT02603432.":[311],"[Table:":[312],"see":[313],"text]":[314]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-02-24T00:00:00"}